Aethlon Medical, Inc. (AEMD)
1.82
-0.11
(-5.70%)
USD |
NASDAQ |
Sep 04, 16:00
1.79
-0.03
(-1.65%)
After-Hours: 20:00
Aethlon Medical Shareholders Equity (Quarterly) : 5.199M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.199M |
| March 31, 2026 | 4.886M |
| December 31, 2025 | 6.713M |
| September 30, 2025 | 5.746M |
| June 30, 2025 | 3.424M |
| March 31, 2025 | 5.124M |
| December 31, 2024 | 4.334M |
| September 30, 2024 | 6.019M |
| June 30, 2024 | 8.713M |
| March 31, 2024 | 5.766M |
| December 31, 2023 | 7.611M |
| September 30, 2023 | 10.32M |
| June 30, 2023 | 13.11M |
| March 31, 2023 | 15.06M |
| December 31, 2022 | 17.28M |
| September 30, 2022 | 19.87M |
| June 30, 2022 | 15.06M |
| March 31, 2022 | 17.13M |
| December 31, 2021 | 20.70M |
| September 30, 2021 | 23.04M |
| June 30, 2021 | 24.87M |
| March 31, 2021 | 9.431M |
| December 31, 2020 | 11.57M |
| September 30, 2020 | 13.70M |
| June 30, 2020 | 15.32M |
| Date | Value |
|---|---|
| March 31, 2020 | 9.410M |
| December 31, 2019 | 3.934M |
| September 30, 2019 | 0.1492M |
| June 30, 2019 | 1.145M |
| March 31, 2019 | 2.425M |
| December 31, 2018 | 3.292M |
| September 30, 2018 | 4.128M |
| June 30, 2018 | 5.218M |
| March 31, 2018 | 6.134M |
| December 31, 2017 | 4.697M |
| September 30, 2017 | 0.1089M |
| June 30, 2017 | -0.8653M |
| March 31, 2017 | 0.6764M |
| December 31, 2016 | 0.0745M |
| September 30, 2016 | -0.0676M |
| June 30, 2016 | 0.4333M |
| March 31, 2016 | 1.553M |
| December 31, 2015 | 2.750M |
| September 30, 2015 | 3.901M |
| June 30, 2015 | 5.075M |
| March 31, 2015 | 0.6155M |
| December 31, 2014 | 1.217M |
| September 30, 2014 | -3.418M |
| June 30, 2014 | -3.691M |
| March 31, 2014 | -14.95M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Abbott Laboratories | 51.11B |
| AngioDynamics, Inc. | 170.82M |
| Alphatec Holdings, Inc. | 11.53M |
| AtriCure, Inc. | 516.43M |
| Baxter International, Inc. | 6.206B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.235M |
| Total Liabilities (Quarterly) | 1.036M |
| Debt to Equity Ratio | 0.0707 |
| Current Ratio | 5.035 |
| Net Debt Paydown Yield | 4.68% |